Download PDF
Clin Colon Rectal Surg 2009; 22(1): 034-040
DOI: 10.1055/s-0029-1202884
Published by Thieme Medical Publishers

Venous Thromboembolic Disease in Colorectal Patients

Michael P. McNally1 , Christopher J. Burns1
  • 1Department of Surgery, Division of Colon and Rectal Surgery, National Naval Medical Center, Bethesda, Maryland
Further Information

Publication History

Publication Date:
09 March 2009 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Venous thromboembolic disease, which includes deep vein thromboses as well as pulmonary emboli, can be a significant complication in the postoperative patient. In particular, colorectal patients often carry a higher risk for venous thromboembolism when compared with patients undergoing other operative procedures. Features unique to colorectal patients are the high incidence of inflammatory bowel disease or malignancy. Typically, these patients will undergo lengthy pelvic procedures, which also contribute to a cumulative risk of venous thrombosis. It is critical that all patients and the proposed operative procedure are appropriately risk stratified. Risk stratification allows for easier implementation of an appropriate prophylactic strategy. There are a wide range of safe and effective mechanical and pharmacologic measures available. The authors provide very specific recommendations, but note that clinical judgment plays a significant role.

KEYWORDS

Deep vein thrombosis - pulmonary embolism - prophylaxis - venous thromboembolism - colorectal surgery

REFERENCES

  • 1 Horlander K T, Mannino D M, Leeper K V. Pulmonary embolism mortality in the United States, 1979–1998: an analysis using multiple-cause mortality data.  Arch Intern Med. 2003;  163 1711-1717
    CrossrefPubMedGoogle Scholar
  • 2 Anderson Jr F A, Wheeler H B, Goldberg R J et al.. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.  Arch Intern Med. 1991;  151(5) 933-938
    CrossrefPubMedGoogle Scholar
  • 3 Silverstein M D, Heit J A, Mohr D N, Petterson T M, O'Fallon W M, Melton III L J. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.  Arch Intern Med. 1998;  158(6) 585-593
    CrossrefPubMedGoogle Scholar
  • 4 Sandler D A, Martin J F. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?.  J R Soc Med. 1989;  82 203-205
    CrossrefPubMedGoogle Scholar
  • 5 Seddighzadeh A, Zurawska U, Shetty R, Goldhaber S Z. Venous thromboembolism in patients undergoing surgery: low rates of prophylaxis and high rates of filter insertion.  Thromb Haemost. 2007;  98(6) 1220-1225
    PubMedGoogle Scholar
  • 6 Yu H T, Dylan M L, Lin J et al.. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism.  Am J Health Syst Pharm. 2007;  64 69-76
    CrossrefPubMedGoogle Scholar
  • 7 Virchow R LK. Translation in Matzdorff AC, Bell WR, trans Thrombosis and embolie (1846–1856). Canton, MA; Science History Publications 1998 Originally published in German as “Thrombose und Embolie. Gefässentzündung und septische Infektion,” Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Frankfurt am Main: Von Meidinger & Sohn; 1856:219–732
    Google Scholar
  • 8 Anning S T. The historical aspects of venous thrombosis.  Med Hist. 1957;  1 28-37
    CrossrefPubMedGoogle Scholar
  • 9 Kikura M, Takada T, Sato S. Age- and sex-specific incidence, risk, and latency period of a perioperative acute thromboembolism syndrome (PATS).  Thromb Haemost. 2004;  91 725-732
    PubMedGoogle Scholar
  • 10 Geerts W H, Graham F P, Heit J A et al.. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126 338S-400S
    CrossrefPubMedGoogle Scholar
  • 11 Geerts W H, Heit J A, Clagett G P, Pineo G F, Colwell C W, Anderson F A, Wheeler B. Prevention of venous thromboembolism.  Chest. 2001;  119 132S-175S
    CrossrefPubMedGoogle Scholar
  • 12 Iversen L H, Thorlacius-Ussing O. Relationship of coagulation test abnormalities to tomour burden and postoperative DVT in resected colorectal cancer.  Thromb Haemost. 2002;  87 402-408
    PubMedGoogle Scholar
  • 13 Stender M T, Nielsen T S, Frøkjaer J B, Larsen T B, Lundbye-Christensen S, Thorlacius-Ussing O. High preoperative prevalence of deep venous thrombosis in patients with colorectal cancer.  Br J Surg. 2007;  94(9) 1100-1103
    CrossrefPubMedGoogle Scholar
  • 14 Bernstein C N, Blanchard J F, Houston D S et al.. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study.  Thromb Haemost. 2001;  85 430-434
    PubMedGoogle Scholar
  • 15 Solem C A, Loftus E V, Tremaine W J, Sandborn W J. Venous thromboembolism in inflammatory bowel disease.  American Journal of Gastroenterology. 2004;  99(1) 97-101
    CrossrefPubMedGoogle Scholar
  • 16 Anderson F A, Spencer F A. Risk factors for venous thromboembolism.  Circulation. 2003;  107(Suppl 1) I9-I16
    CrossrefPubMedGoogle Scholar
  • 17 Nguyen N T, Cronan M, Braley S, Rivers R, Wolfe B M. Duplex ultrasound assessment of femoral venous flow during laparoscopic and open gastric bypass.  Surg Endosc. 2003;  17(2) 285-290
    CrossrefPubMedGoogle Scholar
  • 18 Lindberg F, Bergqvist D, Rasmussen I. Incidence of thromboembolic complications after laparoscopic cholecystectomy: review of the literature.  Surg Laparosc Endosc. 1997;  7 324-331
    CrossrefPubMedGoogle Scholar
  • 19 Benko T, Cooke E A, McNally M A, Mollan R AB. Graduated compression stockings: knee length or thigh length.  Clin Orthop Relat Res. 2001;  383 197-203
    CrossrefPubMedGoogle Scholar
  • 20 Amaragiri S V, Lees T A. Elastic compression stockings for prevention of deep vein thrombosis.  Cochrane Database Sys Rev. 2008;  (1) , CD001484
    PubMedGoogle Scholar
  • 21 Prins M H, Hirsh J. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism.  Arch Intern Med. 1991;  151 1721-1731
    CrossrefPubMedGoogle Scholar
  • 22 Ginzburg E, Cohn S M, Lopez J, Jackowski J, Brown M, Hameed S M. Miami Deep Vein Thrombosis Study Group . Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma.  Br J Surg. 2003;  90(11) 1338-1344
    CrossrefPubMedGoogle Scholar
  • 23 Geerts W H, Berqvist D, Pineo G F et al.. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.)  Chest. 2008;  133(suppl) 381s-453s
    CrossrefPubMedGoogle Scholar
  • 24 Collins R, Scrimgeor A, Yusuf S. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery.  N Engl J Med. 1988;  318 1162-1173
    CrossrefPubMedGoogle Scholar
  • 25 Clagett G P, Reisch J S. Prevention of venous thromboembolism in general surgical patients: results of meta-analysis.  Ann Surg. 1988;  208 227-240
    CrossrefPubMedGoogle Scholar
  • 26 Mismetti P, Laporte S, Darmon J Y et al.. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.  Br J Surg. 2001;  88 913-930
    CrossrefPubMedGoogle Scholar
  • 27 Wille-Jorgensen P, Rasmussen M D, Anderson B R et al.. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery.  Cochrane Database Syst Rev. 2004;  (1) , CD001217
    PubMedGoogle Scholar
  • 28 Kakkar V V, Cohen A T, Edmonson R A et al.. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery.  Lancet. 1993;  341 259-265
    CrossrefPubMedGoogle Scholar
  • 29 Nurmohamed M T, Verhaeghe R, Haas S et al.. A comparative trial of low molecular weight heparin(enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.  Am J Surg. 1995;  169 567-571
    CrossrefPubMedGoogle Scholar
  • 30 Bergqvist D, Matzsch T, Burmark U S et al.. Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis.  Br J Surg. 1988;  75 888-891
    CrossrefPubMedGoogle Scholar
  • 31 McLeod R S, Geerts W H, Sniderman K W et al.. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian Colorectal DVT Prophylaxis Trial: a randomized, double-blind trial.  Ann Surg. 2001;  233 438-444
    CrossrefPubMedGoogle Scholar
  • 32 Koch A, Bouges S, Ziegler S et al.. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analysis.  Br J Surg. 1997;  84 750-759
    CrossrefPubMedGoogle Scholar
  • 33 King D J, Kelton J G. Heparin-associated thrombocytopenia.  Ann Intern Med. 1984;  100 535-540
    PubMedGoogle Scholar
  • 34 Kelton J G, Sheridan D, Santos A et al.. Heparin-induced thrombocytopenia: laboratory studies.  Blood. 1988;  72 925-930
    PubMedGoogle Scholar
  • 35 Warkentin T E, Levine M N, Hirsh J et al.. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.  N Engl J Med. 1995;  332 1330-1335
    CrossrefPubMedGoogle Scholar
  • 36 Martel N, Lee J, Wells P. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylasxis: a meta-analysis.  Blood. 2005;  106 2710-2715
    CrossrefPubMedGoogle Scholar
  • 37 Samama M M, Gerotziafas G T. Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide(fondaparinux).  Thromb Res. 2003;  109 1-11
    CrossrefPubMedGoogle Scholar
  • 38 Eriksson B I, Bauer K A, Lassen M R, Turpie A GG. for the Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study . Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.  N Engl J Med. 2001;  345 1298-1304
    CrossrefPubMedGoogle Scholar
  • 39 Lassen M R, Bauer K A, Eriksson B I, Turpie A GG. for the European Pentasaccharide Hip Elective Surgery Study (EPHESUS) Steering Committee . Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.  Lancet. 2002;  359 1715-1720
    CrossrefPubMedGoogle Scholar
  • 40 Turpie A GG, Bauer K A, Eriksson B I, Lassen M R. for the Steering Committees of the Pentasaccharide Orthopedic Prophylaxis Studies . Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.  Arch Intern Med. 2002;  162 1833-1840
    CrossrefPubMedGoogle Scholar
  • 41 Agnelli G, Bergqvist D, Cohen A T, Gallus A S, Gent M. and PEGASUS Investigators . Randomised clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.  Br J Surg. 2005;  92 1212-1220
    CrossrefPubMedGoogle Scholar
  • 42 Turpie A G, Bauer K A, Caprini J A, Comp P C, Gent M, Muntz J E. Apollo investigators . Fondaparinox combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized double-blind comparison.  J Thromb Haemost. 2007;  5 1854-1861
    CrossrefPubMedGoogle Scholar
  • 43 Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge. An underestimated risk.  Arch Surg. 1992;  127 310-313
    CrossrefPubMedGoogle Scholar
  • 44 Lausen I, Jensen R, Jorgensen L N et al.. Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomized controlled study of prolonged thromboprophylaxis.  Eur J Surg. 1998;  164 657-663
    CrossrefPubMedGoogle Scholar
  • 45 Bergqvist D, Angelli G, Cohen A et al.. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.  N Engl J Med. 2002;  346 975-980
    CrossrefPubMedGoogle Scholar
  • 46 Rasmussen M S, Jorgensen L N, Wille-Jorgensen P et al.. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter open-label study.  J Thromb Haemost. 2006;  4 2384-2390
    CrossrefPubMedGoogle Scholar
  • 47 National Institute for Health and Clinical Excellence .Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing sugery. NICE clinical guideline No. 46:1–160. Available at: http://www.nice.org.uk/CG046 Accessed September 28, 2008
    Google Scholar

Michael P McNallyM.D. 

Department of Surgery, Division of Colon and Rectal Surgery, National Naval Medical Center

8901 Rockville Pike, Bethesda, MD 20889

Email: michael.mcnally@med.navy.mil